Author

Niti Jan

University of South Carolina

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

C.N.R. RaoiD· 1 shared Campbell McInnesiD· 1 shared Cassidy E Socia· 1 shared Danda P. ChapagaiiD· 1 shared Elmar NurmemmedoviD· 1 shared George Merhej· 1 shared Gurusankar Ramamoorthy· 1 shared Ivan BabićiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C.N.R. RaoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Abbapolin inhibitors of the PLK1 PBD as Prostate Cancer Therapeutics, in vivo activity and synergy with androgen therapy

George Merhej, Gurusankar Ramamoorthy, Danda P. Chapagai, Mohammad Esfini Farahani, Yifan Kong, C.N.R. Rao, Jessy M. Stafford, Zachary T. Mack, Cassidy E Socia, S Krishna Kumari, Kristen Hogan, Niti Jan, Maria Marjorette Pena, Elmar Nurmemmedov, Ivan Babić, , Campbell McInnes

This study develops and characterizes abbapolins, non-peptidic PLK1 PBD inhibitors, showing in vivo efficacy against prostate cancer and synergy with enzalutamide.

bioRxiv · Jul 24, 2026 · PreprintCancer Biology